ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,165Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 2604

$606K Total Retail Price of All Prescriptions

Rank: 117 out of 2604

778 Patients Receiving at Least One Drug in Part D
37%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 778 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 778 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 5,159 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LISINOPRIL 627 262 1 3
SIMVASTATIN 573 274 2 2
HYDROCODONE-ACETAMINOPHEN 573 215 S3 2 1
OMEPRAZOLE 493 191 4 5
METFORMIN HCL 398 145 5 7
LEVOTHYROXINE SODIUM 351 193 6 4
AMLODIPINE BESYLATE 346 185 7 6
HYDROCHLOROTHIAZIDE 247 132 8 10
RANITIDINE HCL 233 82 9 25
METOPROLOL TARTRATE 221 68 10 9
TRAMADOL HCL 216 110 11 15
FUROSEMIDE 201 106 12 8
CARVEDILOL 168 124 13 26
ATENOLOL 167 67 14 11
GABAPENTIN 150 48 15 12
CYCLOBENZAPRINE HCL 146 28 R 16 43
ENALAPRIL MALEATE 142 60 17 50
PROAIR HFA 135 36 18 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 75 19 22
ATORVASTATIN CALCIUM 132 53 20 19
LANTUS 131 42 21 40
LOVASTATIN 130 96 22 24
CLOPIDOGREL 130 72 22 39
TRAZODONE HCL 128 31 24 46
GLIPIZIDE 128 74 24 51
COMBIVENT 120 48 26 169
SERTRALINE HCL 111 50 27 23
WARFARIN SODIUM 111 71 27 13
AMITRIPTYLINE HCL 108 23 R 29 82
POTASSIUM CHLORIDE 108 61 29 16
INSULIN SYRINGE 103 38 31 109
NEXIUM 94 28 32 53
ADVAIR DISKUS 94 30 32 41
VENTOLIN HFA 93 0 34 63
PLAVIX 84 52 35 75
CLONIDINE HCL 83 49 36 56
CITALOPRAM HBR 83 31 36 18
ALENDRONATE SODIUM 82 68 38 29
IBUPROFEN 81 17 39 32
NAPROXEN 80 0 40 76
FENTANYL 79 35 S2 41 48
PAROXETINE HCL 77 24 42 62
NOVOLIN 70-30 73 12 43 202
ZOLPIDEM TARTRATE 68 22 44 21
METFORMIN HCL ER 66 47 45 72
MELOXICAM 65 29 46 36
METHADONE HCL 62 0 S2 47 67
GEMFIBROZIL 60 14 48 87
QVAR 57 17 49 151
FLUOXETINE HCL 57 20 49 49
BACLOFEN 55 26 51 101
POLYETHYLENE GLYCOL 3350 55 23 51 42
DICLOFENAC SODIUM 55 0 51 142
ACTOS 55 29 51 116
LOSARTAN POTASSIUM 50 44 55 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.